Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$2.99 - $4.42 $4,485 - $6,630
-1,500 Reduced 6.33%
22,200 $77,000
Q3 2019

Nov 13, 2019

SELL
$2.29 - $4.16 $6,183 - $11,232
-2,700 Reduced 10.23%
23,700 $95,000
Q2 2019

Aug 09, 2019

BUY
$2.28 - $7.35 $60,191 - $194,040
26,400 New
26,400 $85,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.